Details for Patent: 8,869,794
✉ Email this page to a colleague
Which drugs does patent 8,869,794 protect, and when does it expire?
Patent 8,869,794 protects TOBI PODHALER and is included in one NDA.
Summary for Patent: 8,869,794
Title: | Aerosolization apparatus with capsule puncturing member |
Abstract: | An aerosolization apparatus comprises a housing defining a chamber having one or more air inlets. The chamber is sized to receive a capsule which contains an aerosolizable pharmaceutical formulation. A puncturing mechanism is provided within the housing and comprising a puncture member. The puncture member comprises a forward end shaped to form a cutting edge that is effective in cutting the wall of the capsule to create an opening into the capsule. The puncture member also comprises a trailing end shaped so that it has a non-cutting surface that does not cut the wall of the capsule when the trailing end is inserted into the opening created by the forward end. An end section is associated with the housing. The end section is sized and shaped to be received in a user's mouth or nose so that the user may inhale through the end section to inhale aerosolized pharmaceutical formulation that has exited the capsule through the opening created in the capsule. |
Inventor(s): | Tuckwell; Jon David (Cambridgeshire, GB), St. Quintin; Thomas Christopher (Cambridgeshire, GB) |
Assignee: | Novartis Pharma AG (Basel, CH) |
Application Number: | 10/821,652 |
Patent Claim Types: see list of patent claims | Use; Formulation; Delivery; Device; Dosage form; |
Drugs Protected by US Patent 8,869,794
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Speciality Lp | TOBI PODHALER | tobramycin | POWDER;INHALATION | 201688-001 | Mar 22, 2013 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF CYSTIC FIBROSIS PATIENTS WITH PSEUDOMONAS AERUGINOSA | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |